SCHEMBL1389640

SCHEMBL1389640

Cc1cc(/C(CC(c2ccc(-c3ccc(C(=O)NCCC(=O)O)cc3)cc2)c2ccccc2C)=N\O)ccn1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 4/20 0.76
▸ GCG P01275 7/20 0.41
▸ GCGR P47871 6/20 0.41
▸ ADCY6 O43306 1/20 0.41
▸ ADCY3 O60266 1/20 0.41
▸ ADCY9 O60503 1/20 0.41
▸ ADCY5 O95622 1/20 0.41
▸ ADCY8 P40145 1/20 0.41
▸ ADCY7 P51828 1/20 0.41
▸ ADCY2 Q08462 1/20 0.41
▸ ADCY1 Q08828 1/20 0.41
▸ ADCY4 Q8NFM4 1/20 0.41
▸ PSEN1 P49768 1/20 0.40
▸ PSEN2 P49810 1/20 0.40
▸ APH1B Q8WW43 1/20 0.40
▸ NCSTN Q92542 1/20 0.40
▸ APH1A Q96BI3 1/20 0.40
▸ PSENEN Q9NZ42 1/20 0.40
▸ CTSA P10619 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL363600 1.00 GPBAR1 (0.76) GPBAR1GCGGCGRADCY6ADCY3
SCHEMBL10280938 1.00 GPBAR1 (0.76) GPBAR1GCGGCGRADCY6ADCY3
SCHEMBL362982 0.91 GPBAR1 (0.78) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL1390366 0.91 GPBAR1 (0.78) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL364676 0.91 GPBAR1 (0.78) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL363605 0.91 GPBAR1 (0.78) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL362981 0.91 GPBAR1 (0.78) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL10280939 0.91 GPBAR1 (0.78) GPBAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL362804 0.90 GPBAR1 (0.59) GPBAR1GCGGCGRADCY6ADCY3
SCHEMBL363476 0.90 GPBAR1 (0.72) GPBAR1PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 — — EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 — — EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 — — US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885GCG 347/4885GCGR 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback